Hamza Khan

PROGRESS Trial: Earlier TAVR Beats Surveillance in Moderate Aortic Stenosis

The PROGRESS trial found earlier TAVR cut death and heart failure events versus clinical surveillance in moderate aortic stenosis patients with at-risk features.